Emma Hughes

3.2k total citations · 1 hit paper
17 papers, 262 citations indexed

About

Emma Hughes is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Emma Hughes has authored 17 papers receiving a total of 262 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 6 papers in Epidemiology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Emma Hughes's work include HIV/AIDS drug development and treatment (4 papers), Malaria Research and Control (4 papers) and HIV Research and Treatment (2 papers). Emma Hughes is often cited by papers focused on HIV/AIDS drug development and treatment (4 papers), Malaria Research and Control (4 papers) and HIV Research and Treatment (2 papers). Emma Hughes collaborates with scholars based in United States, Uganda and Tanzania. Emma Hughes's co-authors include Erika Wallender, Radojka M. Savić, Francesca Aweeka, Maria Garcia‐Cremades, Anne F. Luetkemeyer, Xin Xu, Nicholas J. Skill, Daniel Raftery, Mary A. Maluccio and Peter R. Williamson and has published in prestigious journals such as The Lancet, Nature Communications and Clinical Infectious Diseases.

In The Last Decade

Emma Hughes

17 papers receiving 259 citations

Hit Papers

Pharmacokinetics and safety of once-yearly lenacapavir: a... 2025 2026 2025 4 8 12
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Pharmacokinetics and safety of once-yearly lenacapavir: a phase 1, open-label study
    2025 14 citations John Ling, Anna Chiu et al. The Lancet profile →

Peers

Emma Hughes
Lynne Gilfillan United States
Yuan Chu China
Tom Holdich United States
Huanying Zhou United States
Florence Marzan United States
L Chiappa Italy
Ayman Akil United States
Ayyappa Chaturvedula United States
Elisa Saccon Sweden
André C. Ferreira Brazil
Lynne Gilfillan United States
Emma Hughes
Citations per year, relative to Emma Hughes Emma Hughes (= 1×) peers Lynne Gilfillan

Countries citing papers authored by Emma Hughes

Since Specialization
Citations

This map shows the geographic impact of Emma Hughes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Hughes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Hughes more than expected).

Fields of papers citing papers by Emma Hughes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Hughes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Hughes. The network helps show where Emma Hughes may publish in the future.

Co-authorship network of co-authors of Emma Hughes

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Hughes. A scholar is included among the top collaborators of Emma Hughes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Hughes. Emma Hughes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ling, John, et al.. (2025). Pharmacokinetics and safety of once-yearly lenacapavir: a phase 1, open-label study. The Lancet. 405(10485). 1147–1154. 14 indexed citations breakdown →
2.
Watts, J. McK., et al.. (2025). Ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein tandem brain biomarker test in the prediction of CT evident brain injury: A prospective evaluation in the emergency department. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 62(5). 412–415. 1 indexed citations
3.
Hughes, Emma, et al.. (2024). Desmopressin dosing in children using real-world data and pharmacokinetic/pharmacodynamic model simulations. Pediatric Research. 97(7). 2449–2453. 1 indexed citations
4.
Ali, Ali M., Erika Wallender, Emma Hughes, Grant Dorsey, & Radojka M. Savić. (2023). Interplay among malnutrition, chemoprevention, and the risk of malaria in young Ugandan children: Longitudinal pharmacodynamic and growth analysis. CPT Pharmacometrics & Systems Pharmacology. 12(5). 656–667. 2 indexed citations
5.
Chen, Fannie W., Joanna P. Davies, Raul Calvo, et al.. (2022). Activation of mitochondrial TRAP1 stimulates mitochondria-lysosome crosstalk and correction of lysosomal dysfunction. iScience. 25(9). 104941–104941. 6 indexed citations
6.
Wallender, Erika, Ali M. Ali, Emma Hughes, et al.. (2021). Identifying an optimal dihydroartemisinin-piperaquine dosing regimen for malaria prevention in young Ugandan children. Nature Communications. 12(1). 6714–6714. 11 indexed citations
7.
Hughes, Emma, Erika Wallender, Richard Kajubi, et al.. (2021). Piperaquine-Induced QTc Prolongation Decreases With Repeated Monthly Dihydroartemisinin-Piperaquine Dosing in Pregnant Ugandan Women. Clinical Infectious Diseases. 75(3). 406–415. 9 indexed citations
8.
Hughes, Emma, Erika Wallender, Ali M. Ali, Prasanna Jagannathan, & Radojka M. Savić. (2021). Malaria PK/PD and the Role Pharmacometrics Can Play in the Global Health Arena: Malaria Treatment Regimens for Vulnerable Populations. Clinical Pharmacology & Therapeutics. 110(4). 926–940. 10 indexed citations
9.
Padilha, Elias Carvalho, Pranav Shah, Amy Q. Wang, et al.. (2020). Metabolism and pharmacokinetics characterization of metarrestin in multiple species. Cancer Chemotherapy and Pharmacology. 85(4). 805–816. 9 indexed citations
10.
Hughes, Emma, Norah Mwebaza, Liusheng Huang, et al.. (2020). Efavirenz-Based Antiretroviral Therapy Reduces Artemether–Lumefantrine Exposure for Malaria Treatment in HIV-Infected Pregnant Women. JAIDS Journal of Acquired Immune Deficiency Syndromes. 83(2). 140–147. 14 indexed citations
11.
Garcia‐Cremades, Maria, Emma Hughes, Erika Wallender, et al.. (2020). Optimizing Hydroxychloroquine Dosing for Patients With COVID‐19: An Integrative Modeling Approach for Effective Drug Repurposing. Clinical Pharmacology & Therapeutics. 108(2). 253–263. 81 indexed citations
12.
Qiu, Jin, Emma Hughes, Waleed Elsegeiny, et al.. (2019). Efficacy of Oral Encochleated Amphotericin B in a Mouse Model of Cryptococcal Meningoencephalitis. mBio. 10(3). 45 indexed citations
13.
Hu, Zongyi, Amy Q. Wang, Pranav Shah, et al.. (2018). Preclinical Pharmacological Development of Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection. The Journal of Infectious Diseases. 217(11). 1761–1769. 11 indexed citations
14.
Wang, Amy Q., Emma Hughes, Wenwei Huang, Edward H. Kerns, & Xin Xu. (2017). Quantification of cyclocreatine in mouse and rat plasma using hydrophilic-interaction ultra-performance liquid chromatography-tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 145. 629–633. 4 indexed citations
15.
Hartman, Tracy L., Liyuan Yang, Matthew Hassink, et al.. (2016). Preclinical evaluation of a mercaptobenzamide and its prodrug for NCp7-targeted inhibition of human immunodeficiency virus. Antiviral Research. 134. 216–225. 14 indexed citations
16.
Hughes, Emma, et al.. (2014). Detection of hepatocellular carcinoma in hepatitis C patients: Biomarker discovery by LC–MS. Journal of Chromatography B. 966. 154–162. 22 indexed citations
17.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lynne Gilfillan Breakdown of academic impact, for papers by Yuan Chu Breakdown of academic impact, for papers by Tom Holdich Breakdown of academic impact, for papers by Huanying Zhou Breakdown of academic impact, for papers by Florence Marzan Breakdown of academic impact, for papers by L Chiappa Breakdown of academic impact, for papers by Ayman Akil Breakdown of academic impact, for papers by Ayyappa Chaturvedula Breakdown of academic impact, for papers by Elisa Saccon Breakdown of academic impact, for papers by André C. Ferreira
Rankless by CCL
2026